近5年高被引文献
Once-Weekly Semaglutide in Adults with Overweight or Obesity
article
Full Text
OpenAlex
3574
FWCI446.71051198
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
article
Full Text
OpenAlex
1860
FWCI624.65538835
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
article
Full Text
OpenAlex
1528
FWCI200.39529634
The hallmarks of cancer metabolism: Still emerging
review
Full Text
OpenAlex
1164
FWCI162.60399299
The cancer metabolic reprogramming and immune response
review
Full Text
OpenAlex
1124
FWCI88.08326401
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
article
Full Text
OpenAlex
1080
FWCI134.68562103
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
article
Full Text
OpenAlex
1020
FWCI880.21162842
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity
article
Full Text
OpenAlex
993
FWCI113.72533883
The metabolism of cancer cells during metastasis
review
Full Text
OpenAlex
891
FWCI79.11478622